Zepbound 10 MG/0.5 ML pen 0.5ML
Ended Awarded Last action
- Contract number
- SPE2DR26F6Y0Z
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $23,909
Award facts
- Contract value 100% obligated
- $23,909.44 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $23,909.44 to AmerisourceBergen Drug Corp for the supply of Zepbound 10 mg/0.5 mL pens (0.5 mL) on January 27, 2026, with an ultimate completion date of January 28, 2026. This firm fixed-price delivery order was competitively awarded without set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The award represents a single task order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, a $999,999,999.00 comprehensive pharmaceutical supply vehicle running through December 2026 that enables the company to deliver a broad range of medications, vaccines, and medical supplies to support military healthcare programs globally.
AmerisourceBergen Drug Corp, a subsidiary of parent company Cencora, Inc., is a major pharmaceutical distributor serving as a critical vendor for federal medical procurement, particularly for the Department of Defense healthcare systems. The company's contract portfolio demonstrates extensive experience supplying diverse pharmaceutical products across multiple therapeutic domains, including diabetes medications, specialty pharmaceuticals, and medical supplies to military treatment facilities and other federal healthcare institutions. This delivery order for Zepbound, a diabetes medication, aligns with the contractor's demonstrated capability to efficiently fulfill government requirements for essential pharmaceutical commodities through open competition.
Quick answers
Who was awarded contract SPE2DR26F6Y0Z?
SPE2DR26F6Y0Z was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 27, 2026.
How much is contract SPE2DR26F6Y0Z worth?
The government has obligated $23,909 on SPE2DR26F6Y0Z.
Is contract SPE2DR26F6Y0Z an order under another contract?
Yes. SPE2DR26F6Y0Z is a delivery order under SPE2DR25D3013, an indefinite delivery contract.
Was contract SPE2DR26F6Y0Z competed?
The extent of competition for SPE2DR26F6Y0Z was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award